XML 55 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Employee Stock and Benefit Plans (Tables)
 12 Months Ended
Oct. 01, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Expense Recognized in the Consolidated Financial Statements Stock-based compensation expense recognized in the consolidated financial statements (in millions):
Fiscal Year EndedOct 1, 2023Oct 2, 2022Oct 3, 2021
RSUs$302.6 $271.8 $316.9 
Options0.1 (0.2)2.2 
Total stock-based compensation expense recognized in the consolidated statements of earnings$302.7 $271.6 $319.1 
Total related tax benefit$50.9 $45.9 $51.6 
Total capitalized stock-based compensation included in net property, plant and equipment on the consolidated balance sheets$3.7 $3.9 $3.7 
Stock Options Granted During the Period, Valuation Assumptions The fair value of stock option awards was estimated at the grant date with the following weighted average assumptions for fiscal 2021:
Stock Options
Granted During the Period
Fiscal Year Ended2021
Expected term (in years)8.1
Expected stock price volatility26.3 %
Risk-free interest rate1.4 %
Expected dividend yield1.6 %
Weighted average grant price$110.46 
Estimated fair value per option granted$27.59 
Stock Option Transactions Stock option transactions for the fiscal year ended October 1, 2023 (in millions, except per share and contractual life amounts):
Shares
Subject to
Options		Weighted
Average
Exercise
Price
per Share		Weighted
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
Outstanding, October 2, 20224.1 $55.86 3.6$117 
Granted— — 
Exercised(2.1)56.55 
Expired/forfeited0.0 50.26 
Outstanding, October 1, 20232.0 55.16 2.372 
Exercisable, October 1, 20232.0 55.16 2.372 
Vested, October 1, 20232.0 55.16 2.372 
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity RSU transactions for the fiscal year ended October 1, 2023 (in millions, except per share and contractual life amounts):
Number
of
Shares		Weighted
Average
Grant Date
Fair Value
per Share		Weighted
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
Nonvested, October 2, 20227.0 $98.88 1.0$587 
Granted4.5 97.66 
Vested(3.1)95.89 
Forfeited/canceled(1.1)95.28 
Nonvested, October 1, 20237.3 99.56 1.0670